Cognitive Dysfunction clinical trials

Explore recruiting cognitive dysfunction clinical trials.

Recruiting cognitive dysfunction studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cognitive Dysfunction trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of treatment of the cholinergic precursor Choline Alfoscerate in mild cognitive dysfunction

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity (OligoTreat)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomised, double-blind, placebo-controlled phase Ib trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of ACD856 in healthy participants

Sweden

Human Pharmacology (Phase I)- Other EU CTIS Study details

Randomized and controlled clinical trial of the efficacy and safety of the use of lidocaine and magnesium sulfate for lung resection surgery using Video-Assisted Thoracic Surgery (VATS)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

The effect of Desflurane versus Sevoflurane versus Propofol on postoperative Delirium in elderly patients undergoing moderate- to high-risk major abdominal surgery – a prospective, double-blinded, randomized, clinical trial RAPID II Trial

Austria

Phase III and phase IV (Integrated) EU CTIS Study details

Conservative vs conventional oxygen administration in critically ill patients: effects on ICU mortality. A multicentre randomized open label clinical trial.

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cognitive Dysfunction trials by city

Cognitive Dysfunction in Toronto Cognitive Dysfunction in Vancouver Cognitive Dysfunction in Montreal Cognitive Dysfunction in Calgary Cognitive Dysfunction in Edmonton Cognitive Dysfunction in Ottawa Cognitive Dysfunction in Winnipeg Cognitive Dysfunction in Quebec City Cognitive Dysfunction in Hamilton Cognitive Dysfunction in Kitchener Cognitive Dysfunction in London Cognitive Dysfunction in Halifax Cognitive Dysfunction in New York Cognitive Dysfunction in Los Angeles Cognitive Dysfunction in Chicago Cognitive Dysfunction in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease